FWM
CRMD icon

Frontier Wealth Management’s CorMedix CRMD Stock Holding History

Frontier Wealth Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-10,000
Closed -$65K – 367
2018
Q4 		$65K Buy
10,000
+6,000
+150% +$40.1K 0.01% 351
2018
Q3 		$19K Buy
+4,000
New +$9.84K ﹤0.01% 390

Other funds holding CRMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $1.12B AUM 390.6% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
EGI
EAM Global Investors Solana Beach, California $34.8M AUM 275.91% 1-Year Est. Return
SC
Spinnaker Capital Boston, Massachusetts $1.08M AUM 45.28% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Frontier Wealth Management's CRMD Position: Q1 2019 in Review

Frontier Wealth Management sold out of CorMedix (CRMD) in Q1 2019, closing a stake of 10,000 shares — an estimated $65K sold.

Frontier Wealth Management first reported a position in CRMD in Q3 2018 and held it in 2 quarters. The position peaked at $65K in Q4 2018. 40 funds tracked by Wall St. Rank hold CRMD as of Q1 2019.

  • Frontier Wealth Management reported no remaining CorMedix position as of Q1 2019 after selling out during the quarter.
  • Frontier Wealth Management sold 10,000 CorMedix shares in Q1 2019, an estimated $65K.
  • Frontier Wealth Management first reported a position in CorMedix in Q3 2018 and held it in 2 quarters.
  • Frontier Wealth Management's CorMedix position peaked at $65K in Q4 2018.
  • 40 funds tracked by Wall St. Rank held CorMedix as of Q1 2019.

Based on Frontier Wealth Management's 13F filing for Q1 2019, filed 15 May 2019.